VX-670

· Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VX-670, covering 2026-02-18 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Long-term Safety and Efficacy of VX-670 in Participants With Myotonic Dystrophy Type I [Phase 2]